(MENAFN- America News Hour) The ‘ North America Drug Delivery
Systems Market report added recently by Market Study Report, LLC, evaluates the
industry in terms of market size, market share, revenue estimation, and
geographical outlook. The study also delivers a precise summary that
illustrates the competitive milieu, growth opportunities and application
landscape of the North America Drug Delivery Systems market depending on the
industry's financial and non-financial impact.
Drug
delivery market in North America is expected to grow from US$ 572,452.95 Mn in
the year 2018 and is expected to reach US$1,074,679.66 Mn by 2027 growing at a
CAGR of 7.4% over the forecast period.Driving factors such as a rising number
of patients suffering from chronic diseases and increasing adoption of non-invasive
drug delivery systems are likely to grow the drug delivery systems market in
the forecast period. Whereas, the product recalls for these products are likely
to impact the growth of the drug delivery systems market during the forecast
period. On the other hand, the development of novel drug delivery solutions is
likely to be a prevalent trend in the market. With the improvements in medical
devices, and certain transdermal delivery technologies, the non-invasive mode
of drug delivery is now ready to compete with traditional methods of oral and
injectable routes of drug delivery.
Request a sample of this premium report at:https://www.marketstudyreport.com/request-a-sample/2106858/?utm_source=Marketwatch-Ram
The
Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive
drug delivery systems which includes drug delivery via topical,
transdermal-active (device- aided enhanced penetration), transdermal-passive,
trans-ocular membrane, trans-mucosal membrane, as well as delivery via an
alveolar membrane from inhaled medication. Patient compliance has been found to
be much higher when administrated by non-invasive routes due to decreased pain
involved in drug delivery and therefore, these techniques are considered to be
a preferred mode of drug delivery. The manufacturing cost may also be less for
non-invasive dosage forms as compared to injections in many cases. For instance,
inhaled insulin appears to be a non-invasive, well-tolerated, and liked
modality of treatment of diabetes. In 2014, MannKind Corporation developed
Afrezza (insulin human) inhalation powder, which was approved by FDA. Thus, due
to advantages offered by non-invasive drug delivery devices, the drug delivery
systems market is expected to witness growth during the forecast period.
The
North America drug delivery systems market on the basis of route of
administration is segmented in to oral, transmucosal, injectable, topical,
implantable and ocular. In 2018, the oral segment held the largest market share
of 50.2% of the drug delivery systems market, by route of administration. The
oral segment is expected to dominate its market share in 2027 owing to ease of
drug administration, a high degree of flexibility on dosages and
cost-effectiveness.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/2106858/?utm_source=Marketwatch-Ram
On the basis of application, the North America drug delivery systems market is segmented into hospitals & clinics, home care settings, and others. In 2018, the hospitals and clinics held the largest market share of 56.0% of the drug delivery systems market, by the application. This segment is also expected to dominate the market in 2027, owing to a large number of the patient population visiting hospitals and clinics. Also hospitals provide diagnosis and treatment for various medical conditions.
On the basis of the distribution channel, the North America drug
delivery systems market is segmented into hospital pharmacies, retail
pharmacies and online pharmacies. In 2018, the hospitals pharmacies held the
largest market share of 68.7% of the drug delivery systems market, by
distribution channel. This segment is also expected to dominate the market in
2027 as hospital pharmacies provide a larger range of medications, including
more specialized and investigational medications.
Some of the major primary and secondary sources for drug
delivery systems included in the report are Centers of Disease Control &
Prevention, Food and Drug Administration, World Health Organization and Others.
TABLE
OF CONTENTS
Part
1. Introduction
1.1
Scope Of The Study
1.2
The Insight Partners Research Report Guidance
Part
2. North America Drug Delivery Systems Market ? Key Takeaways
Part
3. North America Drug Delivery Systems Market ? Market Landscape
3.1
Overview
3.2
Market Segmentation
3.2.1
North America Drug Delivery Systems Market ? By Route Of Administration
3.2.2
North America Drug Delivery Systems Market ? By Application
3.2.3
North America Drug Delivery Systems Market ? By Distribution Channel
3.2.4
North America Drug Delivery Systems Market ? By Country
3.3
PEST Analysis
Part
4. North America Drug Delivery Systems Market- Key Market Dynamics
4.1
Key Market Drivers
4.1.1
Rising Number Of Patients Suffering With Chronic Diseases
4.1.2
Increasing Adoption Towards Non-Invasive Drug Delivery Systems
4.2
Key Market Restraints
4.2.1
Product Recalls For Drug Delivery Systems
4.3
Key Market Opportunities
4.3.1
Rising Compliance Of Patients
4.4
Future Trends
4.4.1
Introduction Of Novel Drug Delivery Systems
4.5
Impact Analysis
Part 5. Drug Delivery Systems Market ? North America Analysis
For more information on this report
at:https://www.marketstudyreport.com/reports/north-america-drug-delivery-systems-market-to-2027?utm_source=Marketwatch-Ram
About Us:
Marketstudyreport.com allows you to manage and
control all corporate research purchases to consolidate billing and vendor
management. You can eliminate duplicate purchases and customize your content
and license management.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:
Website:https://www.marketstudyreport.com
Blog:https://www.marketstudyreport.com/blog/
Market Study Report LLC
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
MENAFN20072019007010068ID1098779562
-MENAFN20072019007010068ID1098779562-->
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.